‘Cannot Have It Both Ways’: AAM Fights MSN’s Corner In Entresto Patent Revival Appeal
‘Pharma Industry Watching Closely’ In Legal Tussle Over Patent Written Description Law
The US Association for Accessible Medicines says it is looking to “protect the public’s interests in ensuring that patents do not let inventors control more than they invented,” as it moved to file in support of MSN Laboratories’ legal tussle with Novartis over a key patent shielding the originator’s $7.8bn Entresto blockbuster.
